Court again permits OxyContin maker Purdue Pharma's bankruptcy plan allowing Sackler family protections to proceed
- Purdue Pharma can proceed with restructuring into a new entity that uses profits to combat the opioid epidemic.
- Sackler family required to pay up to $6 billion over time while gaining legal protections from civil lawsuits.
- Settlement includes funds specifically for victims of the opioid crisis and their families.
- US Trustee appealed the settlement but court ruled it can still move forward.
- Settlement is part of over $50 billion in corporate opioid lawsuit settlements.